Skip to main content

MoneyWorks4Me

Vaishali Pharma - Quaterly Results

07 Aug 2023 Evaluate
The sales figure stood at Rs. 134.23 millions for the June 2023 quarter. The mentioned figure indicates a growth of about 31.86% as compared to Rs. 101.80 millions during the year-ago period.A meek growth of 4.89% was reported for the quarter ended June 2023 to Rs. 15.86  millions from Rs. 15.12 millions.Operating profit surged to 26.69 millions from the corresponding previous quarter of 26.33 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 134.23 101.80 31.86 134.23 101.80 31.86 696.63 758.21 -8.12
Other Income 3.61 4.34 -16.82 3.61 4.34 -16.82 22.29 17.88 24.66
PBIDT 26.69 26.33 1.37 26.69 26.33 1.37 113.58 86.43 31.41
Interest 4.30 5.29 -18.71 4.30 5.29 -18.71 20.09 24.59 -18.30
PBDT 22.39 21.04 6.42 22.39 21.04 6.42 93.49 61.84 51.18
Depreciation 1.20 0.88 36.36 1.20 0.88 36.36 5.04 4.56 10.53
PBT 21.19 20.16 5.11 21.19 20.16 5.11 88.45 57.28 54.42
TAX 5.33 5.04 5.75 5.33 5.04 5.75 22.42 17.05 31.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.04 -0.18 -122.22
PAT 15.86 15.12 4.89 15.86 15.12 4.89 66.03 40.23 64.13
Equity 105.96 105.46 0.47 105.96 105.46 0.47 105.46 105.46 0.00
PBIDTM(%) 19.88 25.86 -23.12 19.88 25.86 -23.12 16.30 11.40 43.03
Peers
Company Name CMP
Redington 344.30
Adani Enterprises 2734.00
Amrapali Industries 34.14
Maxgrow India 178.80
Rashi Peripheral 691.10
View more..